Home
About
Overview
Sharing Data
ORCID
Help
History (26)
[Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer].
Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis.
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
Identification of semaphorin3B as a direct target of p53.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Identification of semaphorin3B as a direct target of p53.
Identification of semaphorin3B as a direct target of p53. Neoplasia. 2002 Jan-Feb; 4(1):82-7.
View in:
PubMed
subject areas
Base Sequence
Binding Sites
Blotting, Northern
Breast Neoplasms
Colony-Forming Units Assay
Consensus Sequence
DNA Damage
DNA Primers
Electrophoretic Mobility Shift Assay
Gene Expression Profiling
Glioblastoma
Humans
Luciferases
Lung Neoplasms
Membrane Glycoproteins
Molecular Sequence Data
Oligonucleotide Array Sequence Analysis
RNA, Messenger
Semaphorins
Tumor Cells, Cultured
Tumor Suppressor Protein p53
Ultraviolet Rays
authors with profiles
Yusuke Nakamura